ArticleFrontiers in medicine2022

Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.

Jianyang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.